관절 재건 기기 시장 : 예측(2024-2029년)

The joint reconstruction devices market is estimated to grow at a CAGR of 4.53% during the forecast period.

Joint replacement is a surgical intervention aimed at alleviating arthritis or damage in a joint. During this procedure, damaged joints are excised and substituted with a prosthesis crafted from metal, plastic, or ceramic materials. The prosthesis is designed to emulate the natural movement of a healthy joint. Devices used in joint replacement serve various functions, such as replacing or substituting the joint's articulating surface, providing primary fixation, and serving as intrinsic elements integral to the joint replacement process. Additionally, ancillary medical devices are also part of this category. This encompasses devices that replace specific joint parts, such as the ball and/or socket in the hip, the two condyles of the femur, and corresponding surfaces of the tibia and/or patella, or trochlear groove of the femur, and the ball and/or socket in the shoulder.

Market Drivers

• Evolving technology

Globally, several transformative technologies have revolutionized the landscape of joint replacement surgeries. Innovations such as robotics, computer navigation, 3D printed implants, smart sensors, wearables, and augmented reality have significantly impacted the field. Technologies such as, computer navigation utilizes specialized software and sensors to create a pre-surgery 3D model of a patient's knee or hip joint. Advanced imaging techniques, including X-ray, MRI, and emerging 3D motion capture technology, play pivotal roles in pre-, intra, and post-operative assessments.

Augmented reality technology is a noteworthy advancement, allowing surgeons to visualize a patient's knee structures and track surgical progress in real-time by overlaying images onto the surgical field.

The integration of "smart" implants and wearable technology has transformed surgical recovery and fostered active collaboration between patients, surgeons, and physical therapists. These innovations mark a significant shift in the approach to joint replacement surgeries, enhancing precision, real-time monitoring, and patient engagement throughout the entire process.

• Growing geriatric population

Globally, the joint reconstruction devices market is significantly impacted by the demographic shift. In 2016, approximately 12.4% of the population in the region of APAC was 60 years or older, but this is projected to increase to more than a quarter - or 1.3 billion- people by 2050. The growing healthcare needs in this context are notable. There are, however, variations across the region in East and North Asia (which includes countries with significant aging populations such as Japan and the Republic of Korea), over a third of the population is expected to be 60 years or older by 2050.

In the European Union, the joint reconstruction devices market is also influenced by the aging population. The population of older people (defined here as those aged 65 years or more) in the EU-27 will increase significantly, rising from 90.5 million at the start of 2019 to 129.8 million by 2050. During this period, the number of people in the EU-27 aged 75-84 years is projected to expand by 56.1%, while the number aged 65-74 years is projected to increase by 16.6%.

In the context of the joint reconstruction devices market and healthcare, it is noteworthy that globally, the older population in less developed regions is growing faster than in the more developed regions. Therefore, older persons will be increasingly concentrated in the less developed regions of the world. Emphasizing the growing importance of healthcare and associated technologies, including joint reconstruction devices.

Market Challenges

• High cost of devices and procedures

The high cost associated with joint reconstruction devices and procedures poses a significant challenge for both patients and healthcare systems. Several factors contribute to this financial burden. Firstly, the intricacy of joint reconstruction devices, frequently crafted with high-grade materials such as titanium and cobalt chrome, leads to elevated production expenses. The manufacturing process necessitates specialized equipment and expertise, further driving up costs.

Additionally, the comprehensive nature of joint reconstruction involves not only the device itself but also various associated expenses. Post-operative care, surgeon fees, and hospital charges collectively contribute to the overall financial burden. These costs are integral components of the joint reconstruction process, adding to the challenges.

Nevertheless, the landscape is evolving with the advent of new technological developments and competitive marketing strategies. These advancements are gradually leading to improved offerings in the field of joint reconstruction, potentially mitigating some of the cost challenges associated with these procedures.

By joint type, the joint reconstruction devices market is divided into knee, hip, shoulder, ankle, and others

In the joint reconstruction market, categorization by joint type has multiple needs. It is primarily propelled by advancements in technology. Knee joint reconstruction, driven by cutting-edge technologies, offers tailored solutions for knee-related conditions, including total knee replacement (TKR) or partial knee replacement (PKR) with advanced femoral and tibial implants. Hip joint reconstruction tackles hip issues through procedures like total hip replacement (THR) and hip resurfacing, with advanced implants such as femoral stems, acetabular cups, and femoral heads.

APAC is anticipated to hold a significant share of the joint reconstruction devices market.

The Asia-Pacific (APAC) region is going to play a significant role in the joint reconstruction devices market, driven by economic development and increased healthcare expenditure. From 2010 to 2018, the APAC economies experienced an average annual growth of 6.4% in real health expenditure as a percentage of GDP per capita. Noteworthy contributors to this growth include China, Timor-Leste, and Turkmenistan, showcasing rapid increases in health expenditure per capita compared to GDP per capita. This trend in healthcare spending is set to change the healthcare landscape, particularly impacting advancements in the joint reconstruction devices market.

Market Developments

• March 2023 - Stryker introduced the exclusive FDA-cleared hydrocarbon-bearing material choice for shoulder hemiarthroplasty. The inaugural procedure in the United States following the De Novo clearance utilized the Tornier Pyrocarbon Humeral Head, marking a significant milestone. Stryker's De Novo request, granted in late 2022, came after the successful completion of an Investigational Device Exemption (IDE) study in collaboration with the FDA.
• March 2021 - Smith+Nephew, the global medical technology company, unveiled its newest Sports Medicine advancements for joint repair and arthroscopic enabling technologies at the American Academy of Orthopaedic Surgeons 2022 Annual Meeting in Chicago, IL. The cutting-edge technologies showcased will encompass the FAST-FIX FLEX Meniscal Repair System, INTELLIO Connected Tower, WEREWOLF FASTSEAL 6.0 Hemostasis Wand, REGENETEN Bioinductive Implant, and CAP-FIX◊ Suture Passer.
• August 2021 - Zimmer Biomet and Canary Medical received FDA De Novo classification and approval to market the world's first and only Smart Knee Implant. The FDA granted authorization for the tibial extension component of Persona IQ®, a groundbreaking smart knee designed for total knee replacement surgery. Persona IQ® integrates Zimmer Biomet's established knee implant, Persona® The Personalized Knee®, with Canary Medical's exclusive implantable sensor technology called canturioTMte tibial extension. This technology measures and assesses various gait metrics, including range of motion, step count, and walking speed, marking a significant advancement in knee replacement surgery.

Company Products

• NewtonTM Balanced Knee System - The NewtonTM Balanced Knee System employs real-time quantifiable soft tissue data, acting as a GPS-like tool for executing patient-specific plans. Utilizing the Newton protocol, surgeons can access comprehensive soft tissue analytics across the full range, predicting postoperative stability before initiating any resections. The system ensures reproducibility through a streamlined and simplified surgical technique, leading to consistent outcomes. With a proven ± .6mm accuracy and precision, and patented image-free GPS active tracking technology, the NewtonTM system offers reliable performance. Notably, its practical efficiency is highlighted by its compact, ambulatory surgery center (ASC)-friendly design, alleviating the burden of capital costs and annual maintenance fees.
• Knee Replacement Products - Zimmer Biomet presents a comprehensive range of Knee Replacement Products, providing surgeons with versatile options for various knee replacement procedures. The offerings include Total Knee Systems, Partial Knee Systems, Bicruciate Preserving Arthroplasty Systems, and Revision Knee Systems. These empower surgeons to adopt a patient-specific approach for each procedure. The Total Knee Systems prioritize natural knee motion, offering extensive implant options for reconstructing the knee based on individual anatomy-covering Primary Knee Systems. Additionally, Zimmer Biomet addresses challenges encountered in revision knee arthroplasty, providing solutions for fixation, constraint, soft tissue, and bony defect management within Revision Knee Systems.
• Hip Implants (Stryker) - In the realm of hip implants, they offer a comprehensive range for total hip arthroplasty, encompassing primary and revision portfolios. These portfolios are meticulously designed, bearing the SOMA imprint, ensuring optimal fit and function. Their offerings include a diverse array of implants, instrumentation, and surgical approach options, with a particular emphasis on novel muscle-sparing techniques for total hip arthroplasty. The commitment extends to staying at the forefront of the latest advancements, including the adoption of innovative approaches like Mako Total Hip Replacement.

Market Segmentation

By Technique

• Joint Replacement
• Osteotomy
• Arthroscopy
• Resurfacing
• Others

By Joint Type

• Knee
• Hip
• Shoulder
• Ankle
• Others

By End-user

• Hospitals
• Clinics
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• UK
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• Japan
• South Korea
• India
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Assumptions

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Force Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. JOINT RECONSTRUCTION DEVICES MARKET BY TECHNIQUE

• 5.1. Introduction
• 5.2. Joint Replacement
• 5.3. Osteotomy
• 5.4. Arthroscopy
• 5.5. Resurfacing
• 5.6. Others

6. JOINT RECONSTRUCTION DEVICES MARKET BY JOINT TYPE

• 6.1. Introduction
• 6.2. Knee
• 6.3. Hip
• 6.4. Shoulder
• 6.5. Ankle
• 6.6. Others

7. JOINT RECONSTRUCTION DEVICES MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Clinics
• 7.4. Others

8. JOINT RECONSTRUCTION DEVICES MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. United States
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. United Kingdom
  • 8.4.2. Germany
  • 8.4.3. France
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. The Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. Japan
  • 8.6.2. China
  • 8.6.3. India
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations

10. COMPANY PROFILES

• 10.1. Stryker
• 10.2. Drager
• 10.3. Exactech
• 10.4. Just Medical Devices (Tianjin) Co. Ltd.
• 10.5. Smith & Nephew
• 10.6. TTK Healthcare
• 10.7. JRI Orthopaedics
• 10.8. Zimmer Biomet
• 10.9. Meril Life
• 10.10. DSM Biomedical